Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ellenberger

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Journal of Neurology|March 26, 2025
MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS RegisterAgni-Maria Konitsioti, Sarah Laurent, David Ellenberger, et al.
JAMA Neurology|February 7, 2018
Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple SclerosisLidia Stork, David Ellenberger, Tim Beißbarth, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Epilepsy as a predictor of disease progression in multiple sclerosisMatthias Grothe, David Ellenberger, Felix von Podewils, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2014
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severityPeter Huppke, Hanna Hummel, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Therapy of highly active pediatric multiple sclerosisPeter Huppke, Brenda Huppke, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|October 8, 2020
Relapsing and progressive MS: the sex-specific perspectivePaulus Stefan Rommer, David Ellenberger, Kerstin Hellwig, et al.
Journal of Neurology|March 22, 2024
Persons with multiple sclerosis older than 55 years: an analysis from the German MS registryYasemin Goereci, David Ellenberger, Paulus Rommer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 2, 2022
Comparison of employment among people with Multiple Sclerosis across EuropeDavid Ellenberger, Tina Parciak, Waldemar Brola, et al.
Frontiers in Neurology|October 5, 2020
Management of MS Patients Treated With Daclizumab - a Case Series of 267 PatientsPaulus S Rommer, Klaus Berger, David Ellenberger, et al.
European Journal of Clinical Investigation|April 15, 2015
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational studyPaulus S Rommer, Karoline Buckow, David Ellenberger, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Journal of Neurology|March 26, 2025
MS treatment trends before, during, and after the COVID-19 pandemic: insights from the German MS RegisterAgni-Maria Konitsioti, Sarah Laurent, David Ellenberger, et al.
JAMA Neurology|February 7, 2018
Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple SclerosisLidia Stork, David Ellenberger, Tim Beißbarth, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2021
Epilepsy as a predictor of disease progression in multiple sclerosisMatthias Grothe, David Ellenberger, Felix von Podewils, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2014
JC virus antibody status in a pediatric multiple sclerosis cohort: prevalence, conversion rate and influence on disease severityPeter Huppke, Hanna Hummel, David Ellenberger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2017
Therapy of highly active pediatric multiple sclerosisPeter Huppke, Brenda Huppke, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|October 8, 2020
Relapsing and progressive MS: the sex-specific perspectivePaulus Stefan Rommer, David Ellenberger, Kerstin Hellwig, et al.
Journal of Neurology|March 22, 2024
Persons with multiple sclerosis older than 55 years: an analysis from the German MS registryYasemin Goereci, David Ellenberger, Paulus Rommer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 2, 2022
Comparison of employment among people with Multiple Sclerosis across EuropeDavid Ellenberger, Tina Parciak, Waldemar Brola, et al.
Frontiers in Neurology|October 5, 2020
Management of MS Patients Treated With Daclizumab - a Case Series of 267 PatientsPaulus S Rommer, Klaus Berger, David Ellenberger, et al.
European Journal of Clinical Investigation|April 15, 2015
Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational studyPaulus S Rommer, Karoline Buckow, David Ellenberger, et al.
Pageof 5